are JAK inhibitors, including ruxolitinib. About XPOVIO® (selinexor) XPOVIO is a first-in-class, oral exportin 1 (XPO1) inhibitor compound for the treatment of cancer. XPOVIO functions by selectively binding to and inhibiting the nuclear export...
Choose Health, an at-home blood testing company, announced the launch of the Comprehensive Liver Function Test, a self-collection blood test measuring 20+ liver health markers for a disease that affects roughly one third of U.S. adults but remains...
Abbott the global healthcare leader, today announced U.S. Food and Drug Administration (FDA) authorization of its Libre Duo 10 Day system, the world's first dual glucose‑ketone sensing technology. The new biowearable is designed to alert people...
Jazz Pharmaceuticals plc announced that the U.S. Food and Drug Administration (FDA) approved two Ziihera® (zanidatamab-hrii)-containing regimens for the first-line treatment of adults with unresectable locally advanced or metastatic HER2-positive...
intense round-the-clock care. About DAYBU® (trofinetide) In Rett syndrome, levels of insulin-like growth factor 1 (IGF-1) in the brain are lower than normal, which is thought to affect nerve function. IGF-1 is a hormone that is important for the...
Upsher-Smith Laboratories, LLC a subsidiary of Bora Pharmaceuticals Co., Ltd. (6472.TW and BORAY.OTCQX), announced the recent launch of Glatiramer Acetate Injection in 20 mg/mL and 40 mg/mL strengths, adding to the Company's portfolio of complex...
Dunbar Pharmaceuticals Ireland's first EU GMP-certified manufacturer of plant-derived cannabinoid active pharmaceutical ingredients (APIs), announced that its plant-derived dronabinol API, WaterClear THC™, is now available across the United...
Tim Czartoski, orthopedic executive and former president of DePuy Synthes U.S. and most recently president of U.S. Surgical and Global R&D at Enovis, has joined the Peptilogics board of directors. His background in leading large orthopedic device...
NMPA granted approval to Geneseeq's PanTRKare™ NTRK1/2/3 Gene Fusion Detection Kit as a companion diagnostic for VELMARTO® (Eratrectinib), a next‑generation highly selective TRK inhibitor independently developed by Vcare PharmaTech. The approval...
Bruker Corporation announced an expanded strategic collaboration with Atinary Technologies Inc., the pioneer of Self-Driving Labs® technologies and AI-driven R&D with applications in pharmaceuticals, chemicals, energy, and materials. Bruker also...
Neurolief, a neuroscience-driven medical technology company developing brain neuromodulation therapies for mental health and neurological conditions, is bringing two prescription therapies to U.S. veterans through a new Department of Veterans...
Avantik announced that its board of directors has appointed Jeffrey Waldman as chief executive officer. He succeeds Mark Zacur, who is retiring after leading Avantik's expansion into a national provider of equipment, consumables and service...
BioVigil, the market leader in automated hand hygiene and infection prevention technology, announced that it has recorded more than 1 billion hand hygiene opportunities (HHOs) since the company’s founding in 2012. This milestone reflects the...
Bruker Corporation announced a majority investment in MIMETAS B.V., a developer of organ-on-a-chip platforms and advanced human tissue and disease models for drug discovery and development. The investment expands Bruker’s post-genomic solutions...
Merck known as MSD outside of the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application (sBLA) for ENFLONSIA™ (clesrovimab-cfor) to expand its indication to...
options.” The approval is based on a comprehensive clinical program including the global Phase 3 FirstLight (TAK-861-3001) and RadiantLight (TAK-861-3002) studies that showed oveporexton offers statistically significant improvements across the full...
Pharmacy costs are consuming a growing share of employer healthcare budgets, but high drug prices and opaque contracts do not explain the entire problem. Employers continue to face spending above expectations despite rebate guarantees, contractual...
Triquetra Health, a clinical-grade supplement company specializing in evidence-based formulation, announced the launch of BioActive Vitamin B1™ Clinical Strength, a complete B1 activation system delivering 600mg benfotiamine at the...
Today, resbiotic® the physician-developed microbiome health company headquartered in Dallas, Texas, announced the launch of two of its science-backed microbiome formulas — resB® Lung Support Probiotic and resG prebeet® Prebiotic — at H-E-B stores...
US Capital Global Securities LLC, the SEC-registered broker-dealer affiliate of the global financial group US Capital Global, is pleased to present eligible investors with the opportunity to participate in a $20 million financing for Thplasma...